• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物使用障碍诊断编码个体的临床特征和纵向结局的差异。

Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes.

机构信息

Palliative Care Program, Division of Geriatric and Palliative Medicine, University of Michigan, Ann Arbor, MI, USA.

Geriatrics Research, Education, and Clinical Center, LTC Charles S. Kettles VA Medical Center, Ann Arbor, MI, USA.

出版信息

J Gen Intern Med. 2023 Feb;38(3):699-706. doi: 10.1007/s11606-022-07732-w. Epub 2022 Jul 11.

DOI:10.1007/s11606-022-07732-w
PMID:35819683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9971398/
Abstract

BACKGROUND

Patterns of opioid use vary, including prescribed use without aberrancy, limited aberrant use, and potential opioid use disorder (OUD). In clinical practice, similar opioid-related International Classification of Disease (ICD) codes are applied across this spectrum, limiting understanding of how groups vary by sociodemographic factors, comorbidities, and long-term risks.

OBJECTIVE

(1) Examine how Veterans assigned opioid abuse/dependence ICD codes vary at diagnosis and with respect to long-term risks. (2) Determine whether those with limited aberrant use share more similarities to likely OUD vs those using opioids as prescribed.

DESIGN

Longitudinal observational cohort study.

PARTICIPANTS

National sample of Veterans categorized as having (1) likely OUD, (2) limited aberrant opioid use, or (3) prescribed, non-aberrant use based upon enhanced medical chart review.

MAIN MEASURES

Comparison of sociodemographic and clinical factors at diagnosis and rates of age-adjusted mortality, non-fatal opioid overdose, and hospitalization after diagnosis. An exploratory machine learning analysis investigated how closely those with limited aberrant use resembled those with likely OUD.

KEY RESULTS

Veterans (n = 483) were categorized as likely OUD (62.1%), limited aberrant use (17.8%), and prescribed, non-aberrant use (20.1%). Age, proportion experiencing homelessness, chronic pain, anxiety disorders, and non-opioid substance use disorders differed by group. All-cause mortality was high (44.2 per 1000 person-years (95% CI 33.9, 56.7)). Hospitalization rates per 1000 person-years were highest in the likely OUD group (831.5 (95% CI 771.0, 895.5)), compared to limited aberrant use (739.8 (95% CI 637.1, 854.4)) and prescribed, non-aberrant use (411.9 (95% CI 342.6, 490.4). The exploratory analysis reclassified 29.1% of those with limited aberrant use as having likely OUD with high confidence.

CONCLUSIONS

Veterans assigned opioid abuse/dependence ICD codes are heterogeneous and face variable long-term risks. Limited aberrant use confers increased risk compared to no aberrant use, and some may already have OUD. Findings warrant future investigation of this understudied population.

摘要

背景

阿片类药物的使用模式存在差异,包括无异常的处方使用、有限的异常使用和潜在的阿片类药物使用障碍(OUD)。在临床实践中,相似的阿片类药物相关国际疾病分类(ICD)代码在整个范围内使用,这限制了我们对不同群体在社会人口因素、合并症和长期风险方面差异的理解。

目的

(1)检查被诊断为阿片类药物滥用/依赖 ICD 代码的退伍军人在诊断时以及在长期风险方面的差异。(2)确定那些有限的异常使用与可能的 OUD 相比,与那些按规定使用阿片类药物的人有更多的相似之处。

设计

纵向观察队列研究。

参与者

根据增强医疗记录审查,将全国退伍军人样本分为(1)可能患有 OUD,(2)有限的异常阿片类药物使用,或(3)按规定、非异常使用。

主要测量指标

诊断时社会人口学和临床因素的比较,以及年龄调整后的死亡率、非致命性阿片类药物过量和诊断后住院率。一项探索性机器学习分析调查了那些有限的异常使用与可能的 OUD 有多相似。

主要结果

退伍军人(n=483)被归类为可能的 OUD(62.1%)、有限的异常使用(17.8%)和规定的非异常使用(20.1%)。年龄、无家可归比例、慢性疼痛、焦虑障碍和非阿片类物质使用障碍因组而异。全因死亡率很高(每 1000 人年 44.2 人(95%CI 33.9,56.7))。每 1000 人年的住院率以可能 OUD 组最高(831.5(95%CI 771.0,895.5)),其次是有限的异常使用组(739.8(95%CI 637.1,854.4))和规定的非异常使用组(411.9(95%CI 342.6,490.4))。探索性分析以高置信度重新分类了 29.1%的有限异常使用为可能的 OUD。

结论

被诊断为阿片类药物滥用/依赖 ICD 代码的退伍军人是异质的,面临着不同的长期风险。与无异常使用相比,有限的异常使用会带来更高的风险,而且有些人可能已经患有 OUD。研究结果值得进一步研究这一研究不足的人群。

相似文献

1
Variation in Clinical Characteristics and Longitudinal Outcomes in Individuals with Opioid Use Disorder Diagnosis Codes.阿片类药物使用障碍诊断编码个体的临床特征和纵向结局的差异。
J Gen Intern Med. 2023 Feb;38(3):699-706. doi: 10.1007/s11606-022-07732-w. Epub 2022 Jul 11.
2
How Is Preoperative Opioid Use Associated With Readmissions and Outcomes in Lower Extremity Trauma?术前使用阿片类药物与下肢创伤患者的再入院及预后有何关联?
Clin Orthop Relat Res. 2025 May 1;483(5):918-927. doi: 10.1097/CORR.0000000000003346. Epub 2024 Dec 20.
3
Supervised dosing with a long-acting opioid medication in the management of opioid dependence.在阿片类药物依赖管理中使用长效阿片类药物进行监督给药。
Cochrane Database Syst Rev. 2017 Apr 27;4(4):CD011983. doi: 10.1002/14651858.CD011983.pub2.
4
Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A systematic review and meta-analysis.患有慢性非癌痛患者中药物性阿片类药物滥用的流行率:系统评价和荟萃分析。
Addiction. 2024 Nov;119(11):1904-1922. doi: 10.1111/add.16616. Epub 2024 Aug 7.
5
Effectiveness of methadone versus buprenorphine in the treatment of opioid use disorder: secondary analyses of prospective cohort study data.美沙酮与丁丙诺啡治疗阿片类物质使用障碍的有效性:前瞻性队列研究数据的二次分析
BMJ Open. 2025 Jun 17;15(6):e095645. doi: 10.1136/bmjopen-2024-095645.
6
"They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.“他们提出问题,但不想得到答案”-退伍军人中断丁丙诺啡治疗阿片类药物使用障碍时对临床沟通的看法。
Subst Use Addctn J. 2024 Oct;45(4):674-681. doi: 10.1177/29767342241251761. Epub 2024 May 20.
7
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration.在退伍军人健康管理局中,有兴奋剂使用障碍和/或阿片类药物使用障碍的患者在治疗接受和住院方面的比较。
J Addict Med. 2024;18(5):561-566. doi: 10.1097/ADM.0000000000001329. Epub 2024 Jun 3.
8
Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder.与新诊断为阿片类药物使用障碍患者的临床医生治疗建议相关的因素。
J Subst Abuse Treat. 2022 Oct;141:108827. doi: 10.1016/j.jsat.2022.108827. Epub 2022 Jun 16.
9
Trends in Opioid Use Disorder in the Veterans Health Administration, 2005-2022.2005 - 2022年退伍军人健康管理局阿片类药物使用障碍趋势
JAMA Netw Open. 2024 Dec 2;7(12):e2451821. doi: 10.1001/jamanetworkopen.2024.51821.
10
Health and Economic Outcomes of Addressing Encampments of Individuals Using Opioids.解决使用阿片类药物者营地问题的健康与经济成果。
JAMA Netw Open. 2025 Jun 2;8(6):e2517095. doi: 10.1001/jamanetworkopen.2025.17095.

引用本文的文献

1
SubgroupTE: Advancing Treatment Effect Estimation with Subgroup Identification.亚组治疗效果分析:通过亚组识别推进治疗效果评估
ACM Trans Intell Syst Technol. 2025 Jun;16(3). doi: 10.1145/3718097. Epub 2025 Jun 10.
2
Heterogeneous Treatment Effect Estimation with Subpopulation Identification for Personalized Medicine in Opioid Use Disorder.阿片类药物使用障碍个性化医疗中基于亚群识别的异质性治疗效果估计
Proc IEEE Int Conf Data Min. 2023 Dec;2023:1079-1084. doi: 10.1109/icdm58522.2023.00127. Epub 2024 Feb 5.
3
Perioperative opioid prescribing and iatrogenic opioid use disorder and overdose: a state-of-the-art narrative review.围手术期阿片类药物处方与医源性阿片类药物使用障碍和过量:最新叙述性综述。
Reg Anesth Pain Med. 2024 Aug 5;49(8):602-608. doi: 10.1136/rapm-2023-104944.

本文引用的文献

1
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.改善阿片类物质使用障碍患者获得循证医学治疗的途径:应对治疗系统中关键障碍的策略
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
2
Drug dependence is not addiction-and it matters.药物依赖不是成瘾——这很重要。
Ann Med. 2021 Dec;53(1):1989-1992. doi: 10.1080/07853890.2021.1995623.
3
Traditional Medicare Spending on Inpatient Episodes as Hospitalizations Decline.传统医疗保险对住院病人的支出随着住院病人的减少而下降。
J Hosp Med. 2021 Nov;16(11):652-658. doi: 10.12788/jhm.3699.
4
Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.评估接受长期阿片类药物治疗慢性疼痛患者的丁丙诺啡转换:系统评价。
JAMA Netw Open. 2021 Sep 1;4(9):e2124152. doi: 10.1001/jamanetworkopen.2021.24152.
5
Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids.长期服用阿片类药物患者中剂量递减与过量用药或心理健康危机的关联。
JAMA. 2021 Aug 3;326(5):411-419. doi: 10.1001/jama.2021.11013.
6
Identifying individuals with opioid use disorder: Validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse.识别患有阿片类药物使用障碍的个体:阿片类药物使用、依赖和滥用的国际疾病分类诊断代码的有效性。
Drug Alcohol Depend. 2021 Apr 1;221:108583. doi: 10.1016/j.drugalcdep.2021.108583. Epub 2021 Feb 13.
7
Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting.比较住院和门诊环境中开始使用阿片类药物使用障碍治疗药物后的过量和住院率。
JAMA Netw Open. 2020 Dec 1;3(12):e2029676. doi: 10.1001/jamanetworkopen.2020.29676.
8
Validity of Incident Opioid Use Disorder (OUD) Diagnoses in Administrative Data: a Chart Verification Study.基于行政数据的偶发性阿片类药物使用障碍(OUD)诊断的有效性:一项图表验证研究。
J Gen Intern Med. 2021 May;36(5):1264-1270. doi: 10.1007/s11606-020-06339-3. Epub 2020 Nov 11.
9
Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and Policy Changes.伴有长期阿片类药物使用的复杂持续性阿片类药物依赖:一个需要明确界定、更好理解、治疗指导和政策改变的灰色地带。
J Gen Intern Med. 2020 Dec;35(Suppl 3):964-971. doi: 10.1007/s11606-020-06251-w. Epub 2020 Nov 6.
10
Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation.基于电子健康记录文档评估疑似阿片类药物使用障碍。
JAMA Netw Open. 2020 Sep 1;3(9):e2015909. doi: 10.1001/jamanetworkopen.2020.15909.